ANGPTL4 and glioblastoma: An 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay revealed that the overexpression of ANGPTL4 reduced the sensitivity of TMZ in GBM cells (Figure 1A and Supplementary Figure S1A).